Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Findings reveal that simufilam treatment reduces seizure severity in a mouse model of tuberous sclerosis, suggesting a potential therapy.
These findings suggest that simufilam treatment in a TSC mouse model prevented the worsening of seizure activity in a dose-dependent manner and supports clinical investigation of simufilam as a potential therapeutic intervention for seizures in TSC.
Stansley et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: